Home ›
Trademark Categories ›
Pharmaceuticals ›
2019 ›
AR ›
ARMAVIUS
Trademark search for:
ARMAVIUS
No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.
Trademark records may change over time.
For the most up-to-date trademark status, domain availability,
and social handle checks, run a live search.
Check latest trademark, domains & social handles
Live search · Most up-to-date results
USPTO Filing History
Key events recorded for this trademark application
2019-07-30 — Application filed
2019-08-02 — Application filed
2019-08-10 — Application filed
2019-09-04 — Assigned to examiner
2019-09-06 — Final disposition recorded
2019-09-06 — Final disposition recorded
2019-09-06 — Final disposition recorded
2019-10-14 — Office action issued
2019-10-14 — Correspondence received in law office
2019-10-15 — Teas/email correspondence entered
2019-10-29 — Approved for pub - principal register
2019-11-05 — Assigned to lie
2019-11-20 — Notification of notice of publication e-mailed
2019-12-10 — Published for opposition
2019-12-10 — Official gazette publication confirmation e-mailed
2020-02-04 — Noa e-mailed - sou required from applicant
2020-06-25 — Sou teas extension received
2020-06-25 — Sou extension 1 filed
2020-06-25 — Sou extension 1 granted
2020-06-27 — Notice of approval of extension request e-mailed
2020-12-08 — Sou teas extension received
2020-12-08 — Sou extension 2 filed
2020-12-08 — Sou extension 2 granted
2020-12-10 — Notice of approval of extension request e-mailed
2021-06-14 — Sou teas extension received
2021-06-14 — Sou extension 3 filed
2021-06-14 — Sou extension 3 granted
2021-06-16 — Notice of approval of extension request e-mailed
2022-01-04 — Sou teas extension received
2022-01-04 — Sou extension 4 granted
2022-01-04 — Sou extension 4 filed
2022-01-06 — Notice of approval of extension request e-mailed
2022-05-23 — Sou teas extension received
2022-05-23 — Sou extension 5 filed
2022-05-27 — Case assigned to intent to use paralegal
2022-05-27 — Sou extension 5 granted
2022-05-28 — Notice of approval of extension request e-mailed
2023-01-12 — Application abandoned
2023-01-13 — Application abandoned
2023-01-13 — Application abandoned
2023-01-13 — Final status recorded
Owner Information
Pfizer Inc.
New York , NY
Pfizer Inc.
New York , NY
Correspondent
Richard A. Friedman PFIZER INC. 235 East 42nd Street New York, NY 10017 UNITED STATES
Filing Details
Filing Date:
2019-07-30
Status Date:
2023-01-13
Disclaimer: This page is informational only and does not constitute legal advice.
Trademark availability depends on jurisdiction, usage, and legal interpretation.